Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Vivian CJ"'
Autor:
Welch DR; Departments of Cancer Biology, Internal Medicine (Hematology/Oncology), Molecular and Integrative Physiology, and Pathology and Laboratory Medicine, The Kansas University Medical Center and The University of Kansas Comprehensive Cancer Center, Kansas City, KS, USA. DWelch@kumc.edu., Larson MA; Transgenic and Gene-Targeting Institutional Facility, The Kansas University Medical Center, Kansas City, KS, USA., Vivian CJ; Department of Cancer Biology, The Kansas University Medical Center, Kansas City, KS, USA., Vivian JL; Transgenic and Gene-Targeting Institutional Facility, The Kansas University Medical Center, Kansas City, KS, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2660, pp. 43-59.
Autor:
Kuravi S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Baker RW; University of Kansas School of Medicine, Kansas City, KS, USA., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Saadi I; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, KS, USA., Lin TL; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Vivian CJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Valluripalli A; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Ganguly S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Cui W; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Elenitoba-Johnson KSJ; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Welch DR; The University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Jensen RA; The University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Saunthararajah Y; Leukemia Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Balusu R; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA. rbalusu@kumc.edu.; The University of Kansas Cancer Center, Kansas City, KS, USA. rbalusu@kumc.edu.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Jan 18; Vol. 6 (1), pp. 3. Date of Electronic Publication: 2022 Jan 18.
Autor:
Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: vsubbiah@mdanderson.org., Kuravi S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA., Ganguly S; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA., Welch DR; The University of Kansas Cancer Center, Kansas City, USA; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, USA., Vivian CJ; The University of Kansas Cancer Center, Kansas City, USA; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, USA., Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA., Hegde A; Department of Hematology/Oncology, University of Alabama, Birmingham, USA., Iyer S; Department of Myeloma and Lymphoma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Behrang A; Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ali SM; Foundation Medicine, Cambridge, USA., Madison RW; Foundation Medicine, Cambridge, USA., Venstrom JM; Foundation Medicine, Cambridge, USA., Jensen RA; The University of Kansas Cancer Center, Kansas City, USA; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA., McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA., Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Balusu R; Division of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA; The University of Kansas Cancer Center, Kansas City, USA. Electronic address: rbalusu@kumc.edu.
Publikováno v:
ESMO open [ESMO Open] 2021 Aug; Vol. 6 (4), pp. 100172. Date of Electronic Publication: 2021 Jul 07.
Autor:
Young ED; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Manley SJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Beadnell TC; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Shearin AE; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Sasaki K; Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University, Kagoshima, Japan., Zimmerman R; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Kauffman E; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Vivian CJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Parasuram A; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Iwakuma T; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Grandgenett PM; Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, USA., Hollingsworth MA; Eppley Institute for Cancer Research, University of Nebraska Medical Center, Omaha, NE, USA., O'Neil M; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA., Welch DR; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS, USA. dwelch@kumc.edu.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. dwelch@kumc.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Jan; Vol. 124 (1), pp. 166-175. Date of Electronic Publication: 2020 Oct 07.
Autor:
Beadnell TC; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., Fain C; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., Vivian CJ; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., King JCG; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., Hastings R; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., Markiewicz MA; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America., Welch DR; Department of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America. Electronic address: dwelch@kumc.edu.
Publikováno v:
Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2020 May 01; Vol. 1866 (5), pp. 165648. Date of Electronic Publication: 2019 Dec 30.
Autor:
Brinker AE; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, Kansas.; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine., Vivian CJ; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine., Beadnell TC; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas.; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine., Koestler DC; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Biostatistics, The University of Kansas Medical Center, Kansas City, Kansas., Teoh ST; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan., Lunt SY; Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan.; Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan., Welch DR; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas. dwelch@kumc.edu.; Department of Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, Kansas.; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine.
Publikováno v:
Cancer research [Cancer Res] 2020 Mar 01; Vol. 80 (5), pp. 1118-1129. Date of Electronic Publication: 2019 Dec 17.
Autor:
Vivian CJ; Department of Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA., Hagedorn TM; Laboratory Animal Resources, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA., Jensen RA; Department of Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA.; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Brinker AE; Department of Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA.; The University of Kansas Cancer Center, Kansas City, KS, USA., Welch DR; Department of Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. dwelch@kumc.edu.; The University of Kansas Cancer Center, Kansas City, KS, USA. dwelch@kumc.edu.
Publikováno v:
Cancer metastasis reviews [Cancer Metastasis Rev] 2018 Dec; Vol. 37 (4), pp. 633-642.
Autor:
Beadnell TC; Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA., Scheid AD; Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA., Vivian CJ; Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA., Welch DR; Department of Cancer Biology, The Kansas University Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. DWelch@KUMC.edu.; The University of Kansas Cancer Center, 3901 Rainbow Blvd., Kansas City, KS, 66160, USA. DWelch@KUMC.edu.
Publikováno v:
Cancer metastasis reviews [Cancer Metastasis Rev] 2018 Dec; Vol. 37 (4), pp. 615-632.
Autor:
Brinker AE; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine, The University of Kansas Medical Center, Kansas City, Kansas., Vivian CJ; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine, The University of Kansas Medical Center, Kansas City, Kansas., Koestler DC; Department of Biostatistics, The University of Kansas Medical Center, Kansas City, Kansas.; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas., Tsue TT; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas., Jensen RA; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.; Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, Kansas., Welch DR; Department of Cancer Biology, The University of Kansas Medical Center, Kansas City, Kansas. dwelch@kumc.edu.; Department of Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine, The University of Kansas Medical Center, Kansas City, Kansas.; The University Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas.
Publikováno v:
Cancer research [Cancer Res] 2017 Dec 15; Vol. 77 (24), pp. 6941-6949. Date of Electronic Publication: 2017 Oct 25.
Autor:
Vivian CJ; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine, Phoenix, Arizona., Brinker AE; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas.; Heartland Center for Mitochondrial Medicine, Phoenix, Arizona.; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas., Graw S; Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas., Koestler DC; Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas., Legendre C; Translational Genomics Research Institute, Phoenix, Arizona., Gooden GC; Translational Genomics Research Institute, Phoenix, Arizona., Salhia B; Translational Genomics Research Institute, Phoenix, Arizona., Welch DR; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas. dwelch@kumc.edu.; Heartland Center for Mitochondrial Medicine, Phoenix, Arizona.; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas.; The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas.
Publikováno v:
Cancer research [Cancer Res] 2017 Nov 15; Vol. 77 (22), pp. 6202-6214. Date of Electronic Publication: 2017 Jun 29.